BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
March 3, 2004
View Archived Issues
Oncology-Focused Igeneon Raises EUR26.7M, Ponders IPO
Igeneon AG raised €26.7 million in a third-round venture financing and landed Burrill & Co., of San Francisco, as a co-lead investor. (BioWorld International)
Read More
Active Biotech Cuts Work Force; Focus Now On Current Portfolio
Read More
How Salmonella Coaxes Gut Cell To Give Warm Embrace
Read More
Monsanto GM Rapeseed Product Receives EU Scientific Clearance
Read More
Phytopharm Raises £6.5M, Plans Partnering Of Obesity Drug P57
Read More
NCI Begins Exploratory Cancer Trials With Xenova's Tariquidar
Read More
Start-Up Vaxon Seeking EUR7M For Novel Cancer Vaccines
Read More
Other News To Note
Read More